Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Adrenocortical Carcinoma × Sunitinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Renal Cell 64 Breast Neoplasms 20 Kidney Neoplasms 19 Gastrointestinal Stromal Tumors 16 Neoplasms 15 Carcinoma, Non-Small-Cell Lung 10 Neoplasm Metastasis 9 Prostatic Neoplasms 8 Urinary Bladder Neoplasms 7 Brain Neoplasms 7 Colorectal Neoplasms 6 Neuroendocrine Tumors 5 Carcinoma, Hepatocellular 5 Carcinoma 5 Thyroid Neoplasms 4 Stomach Neoplasms 4 Small Cell Lung Carcinoma 4 Ovarian Neoplasms 4 Liver Neoplasms 4 Thyroid Cancer, Papillary 3 Sarcoma 3 Pancreatic Neoplasms 3 Leukemia, Myelomonocytic, Chronic 3 Kidney Diseases 3 Glioblastoma 3 Esophageal Neoplasms 3 Clear-cell metastatic renal cell carcinoma 3 Astrocytoma 3 Adenoma, Islet Cell 3 Adenocarcinoma, Follicular 3

Interventions

Mitotane 4 Cisplatin 3 pembrolizumab 2 cixutumumab 2 Etoposide 2 Doxorubicin 2 Dichlorodiphenyldichloroethane 2 sodium thiosulfate 1 relacorilant 1 pegfilgrastim 1 milademetan 1 gossypol acetic acid 1 cabozantinib 1 avelumab 1 antineoplaston AS 2-1 1 antineoplaston A10 1 Sunitinib 1 Streptozocin 1 Platinum 1 Nivolumab 1 Granulocyte Colony-Stimulating Factor 1 Filgrastim 1 Fentanyl 1 Ethane 1 Cytoreduction Surgical Procedures 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00453895 2019-01-31

SIRAC

University of Wuerzburg

Phase 2 Completed

39 enrolled 10 charts

Adrenocortical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡